Literature DB >> 17645834

Successful treatment of metastatic androgen-independent prostate carcinoma in a transsexual patient.

Tanya B Dorff1, Ronald L Shazer, Edward M Nepomuceno, Steven J Tucker.   

Abstract

The occurrence of prostate carcinoma in transsexual patients has rarely been reported. These cases present a unique challenge in that such patients are effectively receiving androgen deprivation therapy. By definition, their disease is androgen-independent prostate cancer, and the role of local therapy is undefined. We report on a male-to-female transsexual patient with metastatic prostate cancer treated successfully with combination chemotherapy after previous standard therapy failed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17645834     DOI： 10.3816/CGC.2007.n.016

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


  9 in total

Review 1.  Cancer in Transgender People: Evidence and Methodological Considerations.

Authors:  Hayley Braun; Rebecca Nash; Vin Tangpricha; Janice Brockman; Kevin Ward; Michael Goodman
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

Review 2.  Prostate cancer in transgender women: considerations for screening, diagnosis and management.

Authors:  Fionnuala Crowley; Meredith Mihalopoulos; Simita Gaglani; Ashutosh K Tewari; Che-Kai Tsao; Miroslav Djordjevic; Natasha Kyprianou; Rajveer S Purohit; Dara J Lundon
Journal:  Br J Cancer       Date:  2022-10-19       Impact factor: 9.075

Review 3.  Embryologic and hormonal contributors to prostate cancer in transgender women.

Authors:  Simita Gaglani; Rajveer S Purohit; Ashutosh K Tewari; Natasha Kyprianou; Dara J Lundon
Journal:  Am J Clin Exp Urol       Date:  2022-04-15

Review 4.  Every urologist and oncologist should know about treating sexual and gender minority prostate cancer patients: translating research findings into clinical practice.

Authors:  B R Simon Rosser; G Nic Rider; Aditya Kapoor; Kristine M C Talley; Ryan Haggart; Nidhi Kohli; Badrinath R Konety; Darryl Mitteldorf; Elizabeth J Polter; Michael W Ross; William West; Christopher Wheldon; Morgan Wright
Journal:  Transl Androl Urol       Date:  2021-07

5.  Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy.

Authors:  Rafal Turo; Samer Jallad; Stephen Prescott; William Richard Cross
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

6.  Understanding Prostate Cancer in Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women: A Review of the Literature.

Authors:  B R Simon Rosser; Shanda L Hunt; Benjamin D Capistrant; Nidhi Kohli; Badrinath R Konety; Darryl Mitteldorf; Michael W Ross; Kristine M Talley; William West
Journal:  Curr Sex Health Rep       Date:  2019-11-08

7.  Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals.

Authors:  Jamie D Weinand; Joshua D Safer
Journal:  J Clin Transl Endocrinol       Date:  2015-06

Review 8.  Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow?

Authors:  Mary C Farach-Carson; Sue-Hwa Lin; Theresa Nalty; Robert L Satcher
Journal:  Front Oncol       Date:  2017-08-07       Impact factor: 6.244

Review 9.  Gynaecological aspects of the treatment and follow-up of transsexual men and women.

Authors:  S Weyers; P De Sutter; S Hoebeke; G Monstrey; G 'T Sjoen; H Verstraelen; J Gerris
Journal:  Facts Views Vis Obgyn       Date:  2010
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.